Figure 7.
Systemic absolute monocyte blood count was lowered with SCD treatment from 0.47 ± 0.09 (pretreatment) to posttreatment of 0.16 ± 0.02 K/μL (n = 9, p = 0.007 (∗)). This lower monocyte count persisted at the 1-week (0.18 ± 0.02 K/μL) and 2-week (0.16 ± 0.02 K/μL) posttherapy monitoring periods.